Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group
- Mulder R. L.
- Font-Gonzalez A.
- van Dulmen-den Broeder E.
- Quinn G. P.
- Ginsberg J. P.
- Loeffen E. A. H.
- Hudson M. M.
- Burns K. C.
- van Santen H. M.
- Berger C.
- Diesch T.
- Dirksen U.
- Giwercman A.
- Gracia C.
- Hunter S. E.
- Kelvin J. F.
- Klosky J. L.
- Laven J. S. E.
- Lockart B. A.
- Neggers S. J. C. M. M.
- Peate M.
- Phillips B.
- Reed D. R.
- Tinner E. M. E.
- Byrne J.
- Veening M.
- van de Berg M.
- Verhaak C. M.
- Anazodo A.
- Rodriguez-Wallberg K.
- van den Heuvel-Eibrink M. M.
- Asogwa O. A.
- Brownsdon A.
- Wallace W. H.
- Green D. M.
- Skinner R.
- Haupt R.
- Kenney L. B.
- Levine J.
- van de Wetering M. D.
- Tissing W. J. E.
- Paul N. W.
- Kremer L. C. M.
- Inthorn J.
- Anderson R. A.
- Barnbrock A.
- Beck J. D.
- Bos A. M. E.
- Calaminus G.
- Constine L. S.
- Demeestere I.
- Denzer C.
- Grabow D.
- di Iorgi N.
- Hoefgen H. R.
- Jahnukainen K.
- Kaatsch P.
- Kebudi R.
- Lambalk C.
- Langer T.
- Loonen J.
- Lorenzo A.
- Meacham L. R.
- Meissner A.
- Mitchell R. T.
- Nahata L.
- Ranft A.
- Dinkelman-Smit M.
- Stern C.
- Stutz-Grunder E.
- Tournaye H.
- van Dorp W.
- van Pelt A. M. M.
- de Vries A.
- Yu R.
DOIAbstract
Patients with childhood, adolescent, and young adult cancer who will be treated with gonadotoxic therapies are at increased risk for infertility. Many patients and their families desire biological children but effective communication about treatment-related infertility risk and procedures for fertility preservation does not always happen. The PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group reviewed the literature and developed a clinical practice guideline that provides recommendations for ongoing communication methods for fertility preservation for patients who were diagnosed with childhood, adolescent, and young adult cancer at age 25 years or younger and their families. Moreover...
Add to ORKG